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Psychoneuroimmunology or Immunopsychiatry?
Carmine M. Pariante, MD, FRCPsych, PhD
Stress, Psychiatry and Immunology Laboratory, Department of Psychological Medicine, Institute 
of Psychiatry, Psychology and Neuroscience, King’s College London, London UK
Studying the communication between the brain and the immune system, a discipline 
generally known as psychoneuroimmunology, is a hot area in psychiatry and neuroscience 
research, and has led to the introduction of a new term to define the field: 
immunopsychiatry.1 The review by Khandaker and colleagues in this issue of The Lancet 
Psychiatry2 specifically “considers whether we are entering a new era of immunopsychiatry 
that will change our understanding of the brain’s maladies”. Why a new name? To 
paraphrase Shakespeare’s Juliet, that which we call psychoneuroimmunology by any other 
name would smell as sweet. I would like to propose that these two names – 
psychoneuroimmunology and immunopsychiatry – represent two different conceptualisation 
of the brain-immune communication. While advocates of both terms acknowledge 
bidirectional communication between these two systems, I would argue that the recent use 
of the term immunopsychiatry represents a hierarchical shift: it suggests that our brain no 
longer governs the immune system, but, on the contrary, that our behaviours and emotions 
are governed by peripheral immune mechanisms. You cannot cure yourself of a fever by 
meditation, but fever can make you sad and grumpy.
Psychoneuroimmunology originally implied a bidirectional communication between the 
brain and the immune system on “equal terms”, with an emphasis on the notion that 
psychological and neural phenomena can influence the immune system.3 In their 1982 
seminal paper, Bovbjerg and his colleagues4 demonstrated that the administration of 
saccharin together with the immunosuppressant, cyclophosphamide, led to a conditioned 
response, so that eventually saccharin alone was able to suppress the immune system. The 
hierarchical model was very clear: a nerve impulse due to a taste stimulus had profound 
effects on the immune system. Dozens of studies in the 1980s then examined the 
relationship between major depression and the immune system, based on the model that 
depression as a mental state was able to influence the immune system.5 More controversial 
studies reported that psychosocial interventions could prolong survival in cancer patients by 
improving immune function,6 and attempts to modify the immune system through hypnosis 
and relaxation.7
In the 1990s, two factors drove a conceptual shift in the field that led to the reversal of the 
hierarchy between the brain and the immune system. First, studies using animal models 
showed clear molecular mechanisms by which immune activation leads to behavioural 
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changes, especially changes resembling depressive symptoms;8 and, second, clinical studies 
showed that patients exposed to cytokine therapies for cancers or chronic viral hepatitis 
develop depressive symptoms and other psychiatric adverse effects.9 Later, increased 
inflammation was described in otherwise healthy individuals with a history of childhood 
trauma, one of the more powerful risk factors for depression,10 implying a potentially 
“causal” role of the increased inflammation in the future onset of depression. The time was 
ripe for affirming that the immune system can “subjugate the brain” in inducing behavioural 
changes and psychiatric symptoms.11 Finally, the most recent studies have shown that 
increased inflammation is present not only in depression but also in psychosis and other 
psychiatric disorders, as discussed in the review by Khandaker and colleagues.2
It is important to consider two more points for discussion. First, as raised by Khandaker and 
colleagues,2 the initial evidence linking immune activation to psychiatric disorders comes 
from studies in patients with infections, some conducted more than one century ago, and 
again implying that the infections (most likely through immune activation) can induce 
behavioural changes and psychiatric symptoms. Second, this theoretical shift in the brain-
body hierarchy does not minimise the importance of psychosocial factors for immune 
regulation, as shown by recent evidence that disruption of immune function by 
psychological stress impairs wound-healing.12
The introduction of the term immunopsychiatry has created the opportunity of managing 
psychiatric disorders through novel treatment approaches targeting the immune system. 
Randomised controlled studies using anti-inflammatories for depression have shown 
therapeutic effects,13 and extended the use of these drugs to other psychiatric disorders13 
and to prophylactic interventions.14 More importantly, this new theoretical approach 
facilitates the identification of biological mechanisms and therapeutic interventions with 
well-defined, hypothesis-based immune mechanisms and pharmacological targets. This, 
together with the introduction of the notion of psychiatric disorders as disorders with 
biological changes that are outside the brain and measureable in the blood, could close the 
gap between psychiatry and the rest of medicine, potentially reducing the stigma associated 
with mental health problems.
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